PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46
Media Pack
News

Current Edition

Volume 7 Issue 4
Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Aurisco – 04/02/2025
Biopharma Group – 19th March 2025
Volume 6 Issue 1

Are Nitrosamines a Concern for Biologic Manufacturers?

The discovery of nitrosamine genotoxins in several pharmaceuticals has led to monitoring and re-evaluation of manufacturing practices for those products considered a...
12 July 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

Global Sterile Manufacturing and Lyophilization Capabilities of Large and Small Molecule Biologics – PCI Shows the Way

PCI’s global manufacturing capabilities are in complex formulations, high potency, and lyophilization and your capabilities cover a broad range of injectables includi...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

High Accuracy Flow Meter for Low Flow Measurements

With the growing popularity of micro-bioreactors, perfusion, as well as cell & gene therapy applications in the life sciences industry, the need to measure low fl...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

Generating Powerful New Pharma Insights from Graphs

Neo4j’s Alex Jarasch explains how knowledge graphs can be a valuable asset for the pharmaceutical industry to extract insights from complex data. An interesting poss...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

Causal Inference and the Future of Clinical Trials

Randomizing every non-essential variable in a scientific experiment to isolate only specific relations is the simple but powerful idea behind Randomized Controlled Tr...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

The Future of the Connected Drug Delivery Device Market: Key Areas for Innovation

The past two decades have seen huge growth in the market for injectable drug delivery products; this shows little sign of slowing down with a further 9.1% of annual g...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

The Opportunities and Obstacles of Filling and Packaging Pre-filled Syringes

Pre-filled syringes (PFS) offer plenty of advantages for injectable drug formulations, but also have challenges ranging from sterile integrity requirements to packagi...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

Are Nitrosamines a Concern for Biologic Manufacturers?

First described over a century ago, the class of organics known as N-nitrosamines are defined by the common structural feature, R2NNO. Since the mid-1950s when their ...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

Analytical Method Release and Stability Platform for RNA Drug Substance

As a leader in cell and gene therapy (CGT) manufacturing and testing for 25 years, Aldevron has built superior analytical capabilities and expertise to support charac...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Volume 6 Issue 1

Beyond Symptom Relief: Human iPSC-derived Models for the Development of Life-changing Therapies for Neurodegenerative Diseases

The complexity and epidemiology of neurodegenerative diseases demands the incorporation of alternative approaches for the development of disease-modifying therapies t...
5 April 2023 Volume 6 Issue 1
Continue Reading →
Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40
Eppendorf – 18.03.2025
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2025, All Rights Reserved – Powered by Teksyte